Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

PHEX gene and hypophosphatemia.

¹Departments of Medicine and Cellular Biology, Duke University Medical Center, Durham, North Carolina 27719, USA. drezn@mc.duke.edu

Kidney International

|January 5, 2000

Summary

Discover the PHEX gene's role in hypophosphatemia, a condition causing low phosphate levels. Mutations in the PHEX gene disrupt phosphate regulation, impacting bone health.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Can vitamin D metabolite measurements facilitate a "treat-to-target" paradigm to guide vitamin D supplementation?

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2015

Same author

Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 IU daily or 50,000 IU monthly in older adults.

The Journal of clinical endocrinology and metabolism·2011

Same author

Correlation among 25-hydroxy-vitamin D assays.

The Journal of clinical endocrinology and metabolism·2008

Same author

Low vitamin D status despite abundant sun exposure.

The Journal of clinical endocrinology and metabolism·2007

Same author

Patient variables impact lumbar spine dual energy X-ray absorptiometry precision.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2006

Same author

Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study.

Annals of the rheumatic diseases·2005

Area of Science:

Biochemistry
Genetics
Endocrinology

Background:

X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia (TIO) share abnormal proximal renal tubular function leading to hypophosphatemia.
The PHEX gene's discovery offers new insights into these phosphate-regulating disorders.

Purpose of the Study:

To elucidate the role of the PHEX gene in the pathophysiology of XLH and TIO.
To understand the mechanisms underlying abnormal phosphate homeostasis and its relation to the PHEX gene.

Main Methods:

Identification of the PHEX gene product as a membrane-bound endopeptidase.
Analysis of potential pathophysiologic cascades involving PHEX gene mutations or overproduction.
Investigating the impact of a putative hormone, phosphatonin, on renal phosphate transport.

Main Results:

PHEX gene inactivation mutations in XLH may cause a failure to clear active phosphatonin, impairing renal phosphate reabsorption.
TIO is potentially caused by tumor overproduction of phosphatonin, overwhelming PHEX transcript capacity.
These findings suggest a central role for phosphatonin and PHEX in phosphate homeostasis.

Conclusions:

The PHEX gene and its product are critical in regulating phosphate levels.
Understanding PHEX and phosphatonin pathways offers new avenues for treating XLH and TIO.
These mechanisms are integral to phosphate, vitamin D, bone, and calcium metabolism.

Related Experiment Videos